2017 annual suzhou technology advanced service enterprise report
According to the notice of the municipal government on identifying the 2017 suzhou advanced technology service enterprise, TOT BIOPHARM was evaluated as the advanced technology service enterprise by the suzhou municipal government.
TOT BIOPHARM Is a high-tech enterprise specializing in the development, production and marketing of anti-tumor new drugs. It is the first MAH pilot enterprise approved by CFDA in jiangsu province and belongs to China's state-supported technological innovation enterprise. The company's products are the national key development category, including: monoclonal antibody and antibody conjugated drugs, oncolytic virus drugs, and special dosage forms of drugs.
With the vision of "improving the quality of life of cancer patients worldwide with innovative technology", TOT BIOPHARM will continue to contribute to the development of China's pharmaceutical industry.